report cover1

Monoclonal Antibody Therapeutics Market “(By Type: Source type (Murine, Chimeric, Humanized and Human) and Production type (in-vivo and in-vitro); By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Neurological Diseases and Others applications)” - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

A renowned research company, Cognizance Market Research, recently added a cutting-edge market report on the ” Monoclonal Antibody Therapeutics Market.” The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2023 to 2030.

Monoclonal Antibody Therapeutics Market Analysis

According to cognizance market research the monoclonal antibody therapeutics market is expected to register a CAGR of 11.04% from 2023 to 2030.

monoclonal antibody therapeutics market

What is Monoclonal Antibody Therapeutics ?

Monoclonal Antibody is a type of protein that is made in the research laboratory and can bind to certain targets in the body. This treatment aims to diminish symptom severity, lower viral loads, and assist in preventing hospitalisations.

Monoclonal antibodies are the foundation of this kind of treatment. These antibodies are comparable to those that your body normally produces in response to an infection. Monoclonal antibodies, on the other hand, are created in large quantities in a lab and are made to detect a particular part of this virus, the spike protein on its outer shell.

These particular antibodies obstruct the virus’ ability to adhere and enter human cells by specifically focusing on the spike protein. they aid the immune system until it can mount a defence on its own.

Monoclonal Antibody Therapeutics  Market Outlook

The market for monoclonal antibodies (mAbs) is predicted to be significantly impacted by the rising prevalence of chronic diseases like cancer, cardiovascular disorders, and others. Similar to this, more mAb therapies are being used for targeted therapies, and patients and doctors are becoming more aware of these therapies, which is predicted to considerably contribute to the market’s growth.

Moreover, the COVID-19 pandemic has improved market expansion prospects by encouraging the creation of a number of mAbs that target the SARS-CoV-2 virus. Because to their efficiency and safety, mAbs are a promising alternative for COVID-19 mitigation. Many of these antibodies have received emergency use authorizations (EUA) from the U.S. FDA. The U.S. FDA has given its approval to more than 100 mAb products, and as more advanced therapy options such as antibody fragments, derivatives, and bispecific antibodies are developed, the range of therapeutic mAb applications is anticipated to expand.

However, the high expenses incurred in the creation of mAbs and the subsequent rise in the cost of mAb therapies may limit market expansion in the near future. For instance, COVID-19 therapy mAbs from GSK & Vir Biotechnology’s sotrovimab and Regeneron’s REGEN-COV (casirivimab and imdevimab) cost approximately USD 1,250 and USD 2,100 per infusion, respectively. For the huge patient populations in poor nations, such high drug prices may impede the adoption of mAbs and restrict their access to mAb therapies.

Segment Analysis:

The monoclonal antibody therapeutics market has been segmented into source type, production type, application, and geography.

Based on source type the monoclonal antibody therapeutics market is segmented into Murine, Chimeric, Humanized and Human.

Based on production type the Monoclonal Antibody Therapeutics market is segmented into in-vivo and in-vitro.

On the basis of application, Monoclonal Antibody Therapeutics Market is segmented into Oncology, Autoimmune Diseases, Infectious Diseases, Neurological Diseases and Others.

Geographical Analysis:

The presence of a highly established healthcare infrastructure, strong patient awareness, and expansion in cancer research potential, among other reasons, contributed to North America having the greatest market share of 46.1% in 2022. Moreover, rising government funding for cancer research and the presence of major companies like Merck & Co., Pfizer Inc., and Amgen Inc. are anticipated to promote market expansion. Because to rising disposable income, a big patient pool for mAb cancer therapies, and a growing emphasis on healthcare, the Asia Pacific area is predicted to grow at the quickest rate, 12.1%, throughout the projection period. Clinical research investment opportunities are appealing in nations like India and China, which is expected to improve the outlook for future research and development.

geographical analysis

The report offers the revenue of the monoclonal antibody therapeutics  market for the period 2020-2030, considering 2020 & 2021 as a historical year, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the monoclonal antibody therapeutics  market for the forecast period. The monoclonal antibody therapeutics  market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the monoclonal antibody therapeutics  market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the monoclonal antibody therapeutics  market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the monoclonal antibody therapeutics  market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the monoclonal antibody therapeutics  market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the monoclonal antibody therapeutics  market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the monoclonal antibody therapeutics  market. The subsequent section of the monoclonal antibody therapeutics  report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.

Monoclonal Antibody Therapeutics  Market Competitive Landscape

By implementing strategic actions that might improve their product portfolio and support growth initiatives, major market participants are fostering market expansion. Some of the major companies in the worldwide monoclonal antibodies market are:

  • Abbott
  • Amgen Inc.
  • Antibody Solutions
  • AstraZeneca
  • Daiichi Sankyo Company, Limited
  • FUJIFILM Diosynth Biotechnologies
  • GSK plc
  • Group Aktiengesellschaft
  • Merck & Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc
  • Sanofi S.A.
  • Sartorius AG
  • UPMC

For instance, Sanofi S.A. and Blackstone Life Sciences collaborated in March 2022 to hasten the development of a subcutaneous Sarclisa mAb formulation for the treatment of multiple myeloma patients. To identify the likely investment opportunities, the study offers a thorough analysis of the monoclonal antibody market’s size, together with current trends and projections for the future.


Monoclonal Antibody Therapeutics  Market, by Source Type

  • Murine
  • Chimeric
  • Humanized
  • Human

Monoclonal Antibody Therapeutics  Market, by Production Type

  • In Vivo
  • In Vitro

Monoclonal Antibody Therapeutics  Market, by Application

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Neurological Diseases
  • Others

Monoclonal Antibody Therapeutics  Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South east asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Complete the form below and we'll get back to you shortly
Table of Content

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.





Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.



Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.

Report Scope:



Market Size

US$ 240.23 Billion (2030)

Compound Annual Growth Rate (CAGR)


Base Year


Forecast Period


Forecast Units

Value (US$ Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Countries Covered

U.S., Canada, Germany, U.K., France, Spain, Italy, Rest of Europe, Japan, China, India, Australia & New Zealand, South Korea, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC, South Africa, Rest of Middle East & Africa

Key Companies Profiled

Abbott, Amgen Inc., Antibody Solutions, AstraZeneca, Daiichi Sankyo Company, Limited, FUJIFILM Diosynth Biotechnologies, GSK plc, Group Aktiengesellschaft, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc, Sanofi S.A., Sartorius AG, UPMC

Key Questions Answered in Monoclonal Antibody Therapeutics Market Report

Monoclonal antibodies are laboratory-made proteins that can bind to specific targets in the body. They are used to treat a wide range of diseases, including cancer, autoimmune diseases, and infectious diseases.

Monoclonal antibody therapeutics work by binding to specific targets in the body and triggering a response from the immune system. This response can help to kill cancer cells, suppress inflammation, or neutralize viruses.

Monoclonal antibody therapeutics are often more targeted and effective than traditional treatments, such as chemotherapy or radiation therapy. They are also generally less toxic and have fewer side effects.

The main challenge facing the monoclonal antibody therapeutics market is the high cost of developing and manufacturing these drugs. This can make them less accessible to patients in developing countries.

The future outlook for the monoclonal antibody therapeutics market is positive. The market is expected to grow rapidly in the coming years, driven by factors such as the increasing prevalence of chronic diseases, the rising demand for targeted therapies, and the development of new monoclonal antibody treatments for a wider range of diseases.

Single User - $4,600.00

It allows one person, the buyer, to have the sole rights and access to the purchased report. Further distribution of the product is strictly prohibited.

It allows the purchased product to be shared among 1-7 employees of your organization within the same geographical location.

It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert